{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:50:19Z","timestamp":1779295819719,"version":"3.51.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870666"],"award-info":[{"award-number":["81870666"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFC0904800"],"award-info":[{"award-number":["2016YFC0904800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00592-019-01363-0","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T23:31:29Z","timestamp":1557876689000},"page":"41-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Metabolomic profile of diabetic retinopathy: a GC-TOFMS-based approach using vitreous and aqueous humor"],"prefix":"10.1007","volume":"57","author":[{"given":"Haiyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenge","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Hai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"issue":"24","key":"1363_CR1","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1001\/jama.2017.7596","volume":"317","author":"L Wang","year":"2017","unstructured":"Wang L et al (2017) Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA 317(24):2515\u20132523","journal-title":"JAMA"},{"issue":"2","key":"1363_CR2","first-page":"302","volume":"12","author":"QH Yang","year":"2019","unstructured":"Yang QH et al (2019) Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and meta-analysis. Int J Ophthalmol 12(2):302\u2013311","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"1363_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09286580701396720","volume":"14","author":"BE Klein","year":"2007","unstructured":"Klein BE (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14(4):179\u2013183","journal-title":"Ophthalmic Epidemiol"},{"issue":"9","key":"1363_CR4","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diacare.26.9.2653","volume":"26","author":"TA Ciulla","year":"2003","unstructured":"Ciulla TA, Amador AG, Zinman B (2003) Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 26(9):2653\u20132664","journal-title":"Diabetes Care"},{"issue":"7","key":"1363_CR5","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1039\/c0mb00341g","volume":"7","author":"X Li","year":"2011","unstructured":"Li X et al (2011) Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: a comparison of stages and subtypes diagnosed by Western and Chinese medicine. Mol BioSyst 7(7):2228\u20132237","journal-title":"Mol BioSyst"},{"issue":"5","key":"1363_CR6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","volume":"33","author":"JW Albers","year":"2010","unstructured":"Albers JW et al (2010) Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care 33(5):1090\u20131096","journal-title":"Diabetes Care"},{"issue":"24","key":"1363_CR7","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"AC Group","year":"2008","unstructured":"Group AC et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358(24):2560\u20132572","journal-title":"N Engl J Med"},{"issue":"5","key":"1363_CR8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/db08-1666","volume":"58","author":"D Brasacchio","year":"2009","unstructured":"Brasacchio D et al (2009) Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58(5):1229\u20131236","journal-title":"Diabetes"},{"issue":"10","key":"1363_CR9","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1084\/jem.20081188","volume":"205","author":"A El-Osta","year":"2008","unstructured":"El-Osta A et al (2008) Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205(10):2409\u20132417","journal-title":"J Exp Med"},{"issue":"15","key":"1363_CR10","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMe0807625","volume":"359","author":"J Chalmers","year":"2008","unstructured":"Chalmers J, Cooper ME (2008) UKPDS and the legacy effect. N Engl J Med 359(15):1618\u20131620","journal-title":"N Engl J Med"},{"issue":"12","key":"1363_CR11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrendo.2010.188","volume":"6","author":"L Pirola","year":"2010","unstructured":"Pirola L et al (2010) Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol 6(12):665\u2013675","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"1363_CR12","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1039\/C7MB00093F","volume":"13","author":"J Fang","year":"2017","unstructured":"Fang J et al (2017) Metabolomics combined with pattern recognition and bioinformatics analysis methods for the development of pharmacodynamic biomarkers on liver fibrosis. Mol BioSyst 13(8):1575\u20131583","journal-title":"Mol BioSyst"},{"key":"1363_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-319-98758-3_4","volume":"1102","author":"SN Baharum","year":"2018","unstructured":"Baharum SN, Azizan KA (2018) Metabolomics in systems biology. Adv Exp Med Biol 1102:51\u201368","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"1363_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12010-018-2899-8","volume":"188","author":"P Tomasova","year":"2019","unstructured":"Tomasova P et al (2019) Metabolomics based on MS in mice with diet-induced obesity and type 2 diabetes mellitus: the effect of vildagliptin, metformin, and their combination. Appl Biochem Biotechnol 188(1):165\u2013184","journal-title":"Appl Biochem Biotechnol"},{"issue":"15","key":"1363_CR15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/rcm.7905","volume":"31","author":"C Jaeger","year":"2017","unstructured":"Jaeger C et al (2017) Compound annotation in liquid chromatography\/high-resolution mass spectrometry based metabolomics: robust adduct ion determination as a prerequisite to structure prediction in electrospray ionization mass spectra. Rapid Commun Mass Spectrom 31(15):1261\u20131266","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1363_CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchromb.2013.08.025","volume":"937","author":"LC Phua","year":"2013","unstructured":"Phua LC et al (2013) Global gas chromatography\/time-of-flight mass spectrometry (GC\/TOFMS)-based metabonomic profiling of lyophilized human feces. J Chromatogr B Analyt Technol Biomed Life Sci 937:103\u2013113","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1363_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.aca.2017.09.042","volume":"995","author":"S Yin","year":"2017","unstructured":"Yin S et al (2017) Optimization of GC\/TOF MS analysis conditions for assessing host-gut microbiota metabolic interactions: Chinese rhubarb alters fecal aromatic amino acids and phenol metabolism. Anal Chim Acta 995:21\u201333","journal-title":"Anal Chim Acta"},{"key":"1363_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2016.05.026","volume":"459","author":"J Gao","year":"2016","unstructured":"Gao J et al (2016) Association between serum bile acid profiles and gestational diabetes mellitus: a targeted metabolomics study. Clin Chim Acta 459:63\u201372","journal-title":"Clin Chim Acta"},{"key":"1363_CR19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cca.2018.09.028","volume":"487","author":"S Wang","year":"2018","unstructured":"Wang S et al (2018) Association of serum metabolites with impaired fasting glucose\/diabetes and traditional risk factors for metabolic disease in Chinese adults. Clin Chim Acta 487:60\u201365","journal-title":"Clin Chim Acta"},{"issue":"2","key":"1363_CR20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel A et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62(2):639\u2013648","journal-title":"Diabetes"},{"issue":"8","key":"1363_CR21","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1158\/1078-0432.CCR-13-1939","volume":"20","author":"Y Qiu","year":"2014","unstructured":"Qiu Y et al (2014) A distinct metabolic signature of human colorectal cancer with prognostic potential. Clin Cancer Res 20(8):2136\u20132146","journal-title":"Clin Cancer Res"},{"key":"1363_CR22","doi-asserted-by":"crossref","first-page":"14101","DOI":"10.1002\/cpbi.11","volume":"55","author":"J Xia","year":"2016","unstructured":"Xia J, Wishart DS (2016) Using metaboanalyst 3.0 for comprehensive metabolomics data analysis. Curr Protoc Bioinform 55:14101\u2013141091","journal-title":"Curr Protoc Bioinform"},{"key":"1363_CR23","doi-asserted-by":"crossref","first-page":"23334","DOI":"10.1038\/srep23334","volume":"6","author":"C Ke","year":"2016","unstructured":"Ke C et al (2016) Metabolic phenotyping for monitoring ovarian cancer patients. Sci Rep 6:23334","journal-title":"Sci Rep"},{"issue":"8","key":"1363_CR24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4331\/wjbc.v3.i8.167","volume":"3","author":"F Zhang","year":"2012","unstructured":"Zhang F, Du G (2012) Dysregulated lipid metabolism in cancer. World J Biol Chem 3(8):167\u2013174","journal-title":"World J Biol Chem"},{"issue":"8","key":"1363_CR25","doi-asserted-by":"crossref","first-page":"e71403","DOI":"10.1371\/journal.pone.0071403","volume":"8","author":"X Wang","year":"2013","unstructured":"Wang X et al (2013) Metabolomics and proteomics annotate therapeutic properties of geniposide: targeting and regulating multiple perturbed pathways. PLoS ONE 8(8):e71403","journal-title":"PLoS ONE"},{"issue":"7","key":"1363_CR26","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1021\/acs.jproteome.8b00169","volume":"17","author":"NR Haines","year":"2018","unstructured":"Haines NR et al (2018) Metabolomics Analysis of Human Vitreous in Diabetic Retinopathy and Rhegmatogenous Retinal Detachment. J Proteome Res 17(7):2421\u20132427","journal-title":"J Proteome Res"},{"issue":"2","key":"1363_CR27","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bbrc.2018.06.097","volume":"503","author":"DD Zhu","year":"2018","unstructured":"Zhu DD et al (2018) The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway. Biochem Biophys Res Commun 503(2):921\u2013929","journal-title":"Biochem Biophys Res Commun"},{"key":"1363_CR28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.exer.2018.05.004","volume":"173","author":"S Vidhya","year":"2018","unstructured":"Vidhya S et al (2018) Free amino acids hydroxyproline, lysine, and glycine promote differentiation of retinal pericytes to adipocytes: a protective role against proliferative diabetic retinopathy. Exp Eye Res 173:179\u2013187","journal-title":"Exp Eye Res"},{"issue":"5","key":"1363_CR29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s11064-015-1798-4","volume":"41","author":"G Sanchez-Chavez","year":"2016","unstructured":"Sanchez-Chavez G et al (2016) Potential role of endoplasmic reticulum stress in pathogenesis of diabetic retinopathy. Neurochem Res 41(5):1098\u20131106","journal-title":"Neurochem Res"},{"issue":"2","key":"1363_CR30","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.3390\/ijms14022559","volume":"14","author":"MS Ola","year":"2013","unstructured":"Ola MS et al (2013) Neurodegeneration and neuroprotection in diabetic retinopathy. Int J Mol Sci 14(2):2559\u20132572","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1363_CR31","first-page":"3539","volume":"16","author":"MT Gong","year":"2018","unstructured":"Gong MT et al (2018) Comprehensive analysis of gene expression profiles associated with proliferative diabetic retinopathy. Exp Ther Med 16(4):3539\u20133545","journal-title":"Exp Ther Med"},{"key":"1363_CR32","doi-asserted-by":"crossref","first-page":"5637130","DOI":"10.1155\/2018\/5637130","volume":"2018","author":"P Romero-Aroca","year":"2018","unstructured":"Romero-Aroca P et al (2018) Glomerular filtration rate and\/or ratio of urine albumin to creatinine as markers for diabetic retinopathy: a ten-year follow-up study. J Diabetes Res 2018:5637130","journal-title":"J Diabetes Res"},{"issue":"8318","key":"1363_CR33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(83)92585-0","volume":"1","author":"T Lauritzen","year":"1983","unstructured":"Lauritzen T et al (1983) Effect of 1\u00a0year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1(8318):200\u2013204","journal-title":"Lancet"},{"issue":"9","key":"1363_CR34","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1016\/S0021-9258(17)35619-3","volume":"261","author":"LC MacGregor","year":"1986","unstructured":"MacGregor LC et al (1986) Altered retinal metabolism in diabetes. I. Microanalysis of lipid, glucose, sorbitol, and myo-inositol in the choroid and in the individual layers of the rabbit retina. J Biol Chem 261(9):4046\u20134051","journal-title":"J Biol Chem"},{"issue":"5","key":"1363_CR35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.0009-9163.2002.00251.x","volume":"61","author":"G Kumaramanickavel","year":"2002","unstructured":"Kumaramanickavel G et al (2002) Inducible nitric oxide synthase gene and diabetic retinopathy in Asian Indian patients. Clin Genet 61(5):344\u2013348","journal-title":"Clin Genet"},{"issue":"30","key":"1363_CR36","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1073\/pnas.0604056103","volume":"103","author":"K Komeima","year":"2006","unstructured":"Komeima K et al (2006) Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci USA 103(30):11300\u201311305","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1363_CR37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/B:AGEN.0000029390.09354.f8","volume":"6","author":"H Ashino","year":"2003","unstructured":"Ashino H et al (2003) Novel function of ascorbic acid as an angiostatic factor. Angiogenesis 6(4):259\u2013269","journal-title":"Angiogenesis"},{"issue":"3","key":"1363_CR38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00418271","volume":"34","author":"AJ Sinclair","year":"1991","unstructured":"Sinclair AJ et al (1991) Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 34(3):171\u2013175","journal-title":"Diabetologia"},{"issue":"6865","key":"1363_CR39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813\u2013820","journal-title":"Nature"},{"issue":"6","key":"1363_CR40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tips.2006.04.003","volume":"27","author":"QJ Wang","year":"2006","unstructured":"Wang QJ (2006) PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci 27(6):317\u2013323","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"1363_CR41","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2337\/diab.43.9.1122","volume":"43","author":"P Xia","year":"1994","unstructured":"Xia P et al (1994) Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43(9):1122\u20131129","journal-title":"Diabetes"},{"issue":"6","key":"1363_CR42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diabetes.47.6.859","volume":"47","author":"D Koya","year":"1998","unstructured":"Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47(6):859\u2013866","journal-title":"Diabetes"},{"issue":"3","key":"1363_CR43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/138920111794480606","volume":"12","author":"MI Galvez","year":"2011","unstructured":"Galvez MI (2011) Protein kinase C inhibitors in the treatment of diabetic retinopathy. Review Curr Pharm Biotechnol 12(3):386\u2013391","journal-title":"Review Curr Pharm Biotechnol"},{"issue":"6","key":"1363_CR44","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/IAE.0b013e3181fe545f","volume":"31","author":"MJ Sheetz","year":"2011","unstructured":"Sheetz MJ et al (2011) Effect of ruboxistaurin (RBX) on visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2). Retina 31(6):1053\u20131059","journal-title":"Retina"},{"issue":"3","key":"1363_CR45","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1167\/iovs.12-11055","volume":"54","author":"MJ Sheetz","year":"2013","unstructured":"Sheetz MJ et al (2013) The effect of the oral PKC beta inhibitor ruboxistaurin on vision loss in two phase 3 studies. Invest Ophthalmol Vis Sci 54(3):1750\u20131757","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1363_CR46","doi-asserted-by":"crossref","first-page":"e1075","DOI":"10.1038\/cddis.2014.23","volume":"5","author":"SP Narayanan","year":"2014","unstructured":"Narayanan SP et al (2014) Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism. Cell Death Dis 5:e1075","journal-title":"Cell Death Dis"},{"key":"1363_CR47","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.preteyeres.2013.06.002","volume":"36","author":"SP Narayanan","year":"2013","unstructured":"Narayanan SP et al (2013) Arginase in retinopathy. Prog Retin Eye Res 36:260\u2013280","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"1363_CR48","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"10","author":"CJ Lynch","year":"2014","unstructured":"Lynch CJ, Adams SH (2014) Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol 10(12):723\u2013736","journal-title":"Nat Rev Endocrinol"},{"key":"1363_CR49","first-page":"2794591","volume":"2016","author":"X Zhao","year":"2016","unstructured":"Zhao X et al (2016) The Relationship between branched-chain amino acid related metabolomic signature and insulin resistance: a systematic review. J Diabetes Res 2016:2794591","journal-title":"J Diabetes Res"},{"issue":"7","key":"1363_CR50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/nu8070405","volume":"8","author":"MS Yoon","year":"2016","unstructured":"Yoon MS (2016) The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients 8(7):405\u2013417","journal-title":"Nutrients"},{"issue":"10","key":"1363_CR51","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.117.029166","volume":"136","author":"BA Kappel","year":"2017","unstructured":"Kappel BA et al (2017) Effect of empagliflozin on the metabolic signature of patients with type 2 diabetes mellitus and cardiovascular disease. Circulation 136(10):969\u2013972","journal-title":"Circulation"},{"issue":"1","key":"1363_CR52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2013.10.036","volume":"232","author":"S Bhattacharya","year":"2014","unstructured":"Bhattacharya S et al (2014) Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization. Atherosclerosis 232(1):191\u2013196","journal-title":"Atherosclerosis"},{"key":"1363_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-019-00018-w","author":"MS Ola","year":"2019","unstructured":"Ola MS, Alhomida AS, LaNoue KF (2019) Gabapentin attenuates oxidative stress and apoptosis in the diabetic rat retina. Neurotox Res. https:\/\/doi.org\/10.1007\/s12640-019-00018-w","journal-title":"Neurotox Res"},{"key":"1363_CR54","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008771","author":"CM Hung","year":"2012","unstructured":"Hung CM et al (2012) mTOR-dependent cell survival mechanisms. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a008771","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"1363_CR55","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1101\/gad.1662308","volume":"22","author":"HC Dan","year":"2008","unstructured":"Dan HC et al (2008) Akt-dependent regulation of NF-\u03baB is controlled by mTOR and Raptor in association with IKK. Genes Dev 22(11):1490\u20131500","journal-title":"Genes Dev"},{"issue":"6","key":"1363_CR56","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1159\/000453207","volume":"40","author":"J Wei","year":"2016","unstructured":"Wei J et al (2016) Blocking mammalian target of rapamycin (mTOR) attenuates HIF-1\u03b1 pathways engaged-vascular endothelial growth factor (VEGF) in diabetic retinopathy. Cell Physiol Biochem 40(6):1570\u20131577","journal-title":"Cell Physiol Biochem"},{"key":"1363_CR57","doi-asserted-by":"crossref","first-page":"589813","DOI":"10.1155\/2011\/589813","volume":"2011","author":"JL Jacot","year":"2011","unstructured":"Jacot JL, Sherris D (2011) Potential therapeutic roles for inhibition of the PI3K\/Akt\/mTOR pathway in the pathophysiology of diabetic retinopathy. J Ophthalmol 2011:589813","journal-title":"J Ophthalmol"},{"issue":"21","key":"1363_CR58","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1101\/gad.1134603","volume":"17","author":"I Adini","year":"2003","unstructured":"Adini I et al (2003) RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development. Genes Dev 17(21):2721\u20132732","journal-title":"Genes Dev"},{"key":"1363_CR59","doi-asserted-by":"crossref","first-page":"9254126","DOI":"10.1155\/2018\/9254126","volume":"2018","author":"LY Herat","year":"2018","unstructured":"Herat LY et al (2018) Focusing on sodium glucose cotransporter-2 and the sympathetic nervous system: potential impact in diabetic retinopathy. Int J Endocrinol 2018:9254126","journal-title":"Int J Endocrinol"},{"issue":"11","key":"1363_CR60","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1039\/C7MB00167C","volume":"13","author":"L Li","year":"2017","unstructured":"Li L et al (2017) Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients. Mol BioSyst 13(11):2392\u20132400","journal-title":"Mol BioSyst"},{"issue":"3\u20134","key":"1363_CR61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cca.2010.10.020","volume":"412","author":"J Lu","year":"2011","unstructured":"Lu J et al (2011) Closing the anion gap: contribution of D-lactate to diabetic ketoacidosis. Clin Chim Acta 412(3\u20134):286\u2013291","journal-title":"Clin Chim Acta"},{"key":"1363_CR62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpba.2015.06.014","volume":"116","author":"CK Chou","year":"2015","unstructured":"Chou CK et al (2015) Elevated urinary D-lactate levels in patients with diabetes and microalbuminuria. J Pharm Biomed Anal 116:65\u201370","journal-title":"J Pharm Biomed Anal"},{"key":"1363_CR63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jchromb.2018.09.004","volume":"1100\u20131101","author":"J Chou","year":"2018","unstructured":"Chou J et al (2018) Fasting serum alphahydroxybutyrate and pyroglutamic acid as important metabolites for detecting isolated post-challenge diabetes based on organic acid profiles. J Chromatogr B Analyt Technol Biomed Life Sci 1100\u20131101:6\u201316","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6","key":"1363_CR64","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4155\/bio.14.307","volume":"7","author":"A Makahleh","year":"2015","unstructured":"Makahleh A, Ben-Hander GM, Saad B (2015) Determination of alpha-ketoglutaric and pyruvic acids in urine as potential biomarkers for diabetic II and liver cancer. Bioanalysis 7(6):713\u2013723","journal-title":"Bioanalysis"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01363-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01363-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01363-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T01:11:31Z","timestamp":1663463491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01363-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1363"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01363-0","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was prospectively approved by the Ethics Committee of Shanghai First People\u2019s Hospital of Shanghai Jiaotong University, and research was conducted in accordance to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"Signed informed consent was obtained from all participants enrolled in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}